Relationship between coronary plaque formation and NAD(P)H oxidase-derived reactive oxygen species - Comparison of intravascular ultrasound finding of atherosclerotic lesions with histochemical characteristics

Kobe Journal of Medical Sciences

Volumn 53, Issue 3, 2007, Pages 107-117

  Terashima, Mitsuyasu ^a   Inoue, Nobutaka ^b   Ohashi, Yoshitaka ^c   Yokoyama, Mitsuhiro ^b  

^a Toyohashi Heart Center Toyohashi   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Miki City Hospital   (Japan)

Author keywords

Atherosclerosis; Coronary plaque; Intravascular ultrasound; NAD(P)H oxidase; Reactive oxygen species

Indexed keywords

HYDROETHIDINE; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DIRECTIONAL ATHERECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR ULTRASOUND; MALE; PROTEIN EXPRESSION;

AGED; ATHERECTOMY, CORONARY; CORONARY ARTERY DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34548407775     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW. 1991. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature. 353:668-670.
2. Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, Gorlin R, Fuster V. 1985. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 5:609-616.
3. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, Itoh H, Yokoyama M. 1999. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation. 100:1494-1498.
4. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M. 2002. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol. 22:1838-1844.
5. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:307-310.
6. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. 2002. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 105:297-303.
7. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. 1987. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 316:1371-1375.
8. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1141-1148.
9. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. 2002. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 105:1656-1662.
10. Hamm CW, Braunwald E. 2000. A classification of unstable angina revisited. Circulation. 102:118-122.
11. Imajoh-Ohmi S, Tokita K, Ochiai H, Nakamura M, Kanegasaki S. 1992. Topology of cytochrome b558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis. J Biol Chem. 267:180-184.
12. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. 1998. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation. 97:135-137.
13. Inoue N, Takeshita S, Gao D, Ishida T, Kawashima S, Akita H, Tawa R, Sakurai H, Yokoyama M. 2001. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis. 155:45-52.
14. Itabe H, Takeshima E, Iwasaki H, Kimura J, Yoshida Y, Imanaka T, Takano T. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J Biol Chem. 269:15274-15279.
15. Lessner SM, Martinson DE, Galis ZS. 2004. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity. Arterioscler Thromb Vasc Biol. 24:2123-2129.
16. Leusen JH, Verhoeven AJ, Roos D. 1996. Interactions between the components of the human NADPH oxidase: intrigues in the phox family. J Lab Clin Med. 128:461-476.
17. Libby P. 1995. Molecular bases of the acute coronary syndromes. Circulation. 91:2844-2850.
18. Matsubara T, Ziff M. 1986. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol. 137:3295-3298.
19. Miller FJ, Jr., Gutterman DD, Rios CD, Heistad DD, Davidson BL. 1998. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 82:1298-1305.
20. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. 2001. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 37:1478-1492.
21. Mohazzab KM, Kaminski PM, Wolin MS. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 266:H2568-2572.
22. Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, Suzuki H, Ohnishi T, Kakuta Y, Nakano T, Yeung AC. 2001. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 37:63-69.
23. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, Fischer C, DeMaria AN. 1991. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 84:1087-1099.
24. Ohara Y, Peterson TE, Harrison DG. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:2546-2551.
25. Pasterkamp G, Schoneveld AH, van der Wal AC, Haudenschild CC, Clarijs RJ, Becker AE, Hillen B, Borst C. 1998. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol. 32:655-662.
26. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 98:2572-2579.
27. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. 1993. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest. 92:1564-1571.
28. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. 2000. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation. 101:598-603.
29. Yamagishi M, Terashima M, Awano K, Kijima M, Nakatani S, Daikoku S, Ito K, Yasumura Y, Miyatake K. 2000. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol. 35:106-111.
30. Yock PG, Linker DT, Angelsen BA. 1989. Two-dimensional intravascular ultrasound: technical development and initial clinical experience. J Am Soc Echocardiogr. 2:296-304.